ArticleJournal of experimental & clinical cancer research : CR2018

Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone.

Changliang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.